“…In the future, new molecular testing technologies, such as multiplex and point-of-care tests, may improve access and facilitate prompt treatment, but their use will require appropriate stewardship in order to discourage unnecessary testing, false-positive results and consequent harm [100]. Major revisions to the commissioning and provision of sexual health services, especially in England, raise opportunities for STI control to be prioritized by local government, but equally present challenges, such as the potential fragmentation of services [101]. The effects of these changes on service access, service provision and quality of care, the size and behavior of at-risk populations, the impact of population-level interventions and evolving testing technologies will shape STI epidemiology in the UK over the coming decade.…”